OncoSec Medical Inc (ONCSQ)

[$Moneypenny$]

This is taken from the 2014 strategic update issued in January. Sometimes we as investors are impatient but it looks like things are really on schedule:

Metastatic melanoma Phase 2 study (OMS-I100)
Complete enrollment in study being led by the University of California San Francisco (UCSF), University of Washington and other U.S. cancer centers
Evaluate dose-intensified treatment schedules
Report interim and final analysis of clinical data
Initiate Phase 2b metastatic melanoma study
Merkel cell carcinoma Phase 2 study (OMS-I110)
Complete enrollment in study being led by the University of Washington and UCSF
Report clinical data
Expand Phase 2 cutaneous T-cell lymphoma study to a multi-institution trial to enhance enrollment and leverage additional expertise in CTCL
Initiate additional Phase 1 study in new solid tumor indication